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Objectives
This review aimed to ascertain the extent to which the
issue of departure from treatment protocol (DTP) is
reported and addressed in published analyses of RCTs.
Methods
One hundred publications of RCTs were randomly
selected from those published in the BMJ, NEJM, JAMA
and Lancet during 2008. Each trial report was reviewed
to determine the extent and nature of reporting on DTP
and whether statistical methods were used to deal with
DTP for both benefit and harms analyses.
Results
Even the most basic adherence information was not pre-
sented in some trials. Forty-two publications did not
state how many patients actually initiated their rando-
mised treatment. Information about treatment disconti-
nuation can be vague and may not allow assessment of
the number of patients who completed the treatment
protocol.
Ninety-eight publications reported at least one form of
DTP, including non-receipt of allocated treatment (39
trials), incomplete treatment in those who initiated allo-
cated treatment (78), switching trial treatments (12),
starting disallowed/non-trial treatment (4), starting open
label treatment out of trial (7), contamination across
groups (3) and other nonadherence to treatment dose or
schedule (23). Treatment providers were reported to be
nonadherent when delivering treatment in 12 trials.
More than half (50 (51%)) of the publications that
reported DTP used some method to deal with it, but
none were based on randomisation-preserving
techniques. The most common method was based on
per protocol (PP) analysis (46) (including one instance
of using inverse probability of censoring weighting)
often labelled as intention to treat (ITT) (18) or modi-
fied ITT (5), but missing data techniques (2) and as
treated analyses (3) were also implemented. Less than
40% (26) of the 69 trials which presented harms analyses
specifically defined harms analysis populations, and the
majority of these definitions were based on actual treat-
ment received (18). The majority (31) of the 43 trials
that did not explicitly specify harms analysis population
appeared to analysed harms outcomes using ITT.
Twelve reports explicitly commented on the fact that
DTP was likely to have influenced the observed treat-
ment effect.
Conclusions
DTP data presented in RCT publications, particularly
related to treatment initiation and discontinuation, may
be ambiguous or scant. Trialists often attempt to deal
with DTP using variations of PP analysis, although they
may be labelled as ITT; randomisation-preserving meth-
ods are not typically used. There appears to be confu-
sion among trialists over the appropriate analysis
population for harms outcomes in the presence of DTP.
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